Mechanistic and functional characterization of a novel microglia-specific PLCG2 p.P522R variant in aging and Alzheimer's disease-related cellular processes
Description of the granted funding
This research project elucidates how recently identified variant in microglia-specific PLCG2 gene (P522R, protective variant) is associated with molecular, cellular, pathophysiological and behavioral aspects of aging and Alzheimer's disease (AD). State-of-the-art in vitro and in vivo models and techniques in combination with up-to-date methodologies will be used to facilitate mechanistic characterization of the variant. It is expected that untangling the protective action(s) exerted by the variant will shed light into the role of microglia and immune system upon aging and AD-associated cellular stress. Furthermore, it is expected that the project pinpoints new therapeutic targets and paves the way for potential treatment strategies, which are based on PLC?2-related modulation of microglia in AD and in other neurodegenerative diseases involving altered immune system function.
Show moreStarting year
2020
End year
2023
Granted funding
Role in consortium of the Academy of Finland
Leader
Funder
Research Council of Finland
Funding instrument
Postdoctoral Researcher
Other information
Funding decision number
330178
Fields of science
Biomedicine
Research fields
Biolääketieteet
Identified topics
brain, neuroscience